Sep 2026 23 The Board of Directors Approves the Half-Yearly Financial Report at 30 June 2026 (Price sensitive) – Courtesy English Translation
Aug 2026 17 Updated Phase III PIVOTAL Results for Nidlegy™ Published in the Journal of Clinical Oncology
